GE Healthcare and Cellular Dynamics International agree to sublicense for cellular assay patents

  GE Healthcare and Cellular Dynamics International agree to sublicense for
                            cellular assay patents

PR Newswire

CHALFONT ST. GILES, UK and MADISON, Wis., Dec. 18, 2012

CHALFONT ST. GILES, UK and MADISON, Wis., Dec. 18, 2012 /PRNewswire/ --GE
Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and
Cellular Dynamics International (CDI), a leading commercial producer of human
induced pluripotent stem (iPS) cell lines and tissue cells, announced today
that GE Healthcare has licensed CDI to develop, manufacture and sell cellular
assays and models derived from induced pluripotent stem (iPS) cells for use in
drug discovery and toxicity screening. The agreement follows the recent
announcement that GE Healthcare has expanded its license with Geron to obtain
exclusive global rights to Geron's intellectual property and know-how for the
development and sale of cellular assays derived from iPS cells. Financial
terms were not disclosed.

As the worldwide pharmaceutical industry seeks to reduce drug development
costs and bring more effective, safer drugs to market, the availability of
more biologically relevant and predictive cell models becomes increasingly
important. GE Healthcare is pioneering the development of human cell-based
assays and models for use in drug discovery and predictive toxicity
screening. In 2010 the company launched Cytiva^TM cardiomyocytes (human heart
cells), stem cell-based assays that are already helping pharmaceutical
companies identify drug candidates that show toxic effects much earlier in the
discovery process.

Cellular Dynamics develops, manufactures and sells human cells based on iPS
cell technology and currently offers iCell® Cardiomyocytes, iCell Neurons
(brain cells), iCell Endothelial Cells (blood vessel cells) and iCell
Hepatocytes (liver cells). CDI has also launched MyCell™ Services, a custom
cell manufacturing service that leverages the ability of iPS cell technology
to make stem cells or terminal cells from any individual, including those with
diseases of interest to pharmaceutical companies and academic scientists.

Dr Amr Abid, General Manager, Cell Technologies, GE Healthcare Life Sciences,
said, "We believe it is important that stem cell-based assays are available to
researchers so that progress can be made in drug discovery; clarity and
freedom to operate is fundamental to advancing the use of such assays. Our
recently extended agreement with Geron provided the foundation for the type of
agreement we are announcing today. GE Healthcare believes that such agreements
are the next step to enabling the wider industry to benefit from the use of
this key intellectual property without violating patent rights. We are
delighted that Cellular Dynamics International is the first company to work
with us to bring greater clarity to the marketplace."

Bob Palay, CEO of Cellular Dynamics International, added, "CDI's mission is
to provide human cell-based research and drug discovery tools that enhance
scientists' ability to better understand human biology, increase efficiency of
the discovery process and ultimately improve human healthcare. The IP space
surrounding stem cell technology is complex. With the licensing of the
GE-Geron intellectual property portfolio, CDI now has more than 700 licensed
or owned patents and patent applications. We have built our IP portfolio
intending to ensure broad freedom to operate and to offer customers products
that they can use with confidence and the knowledge that their subsequent
discoveries are protected by this IP portfolio." 

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging
and information technologies, medical diagnostics, patient monitoring systems,
drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to deliver
better care to more people around the world at a lower cost. In addition, we
partner with healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality around the world. Headquartered in the
United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE:
GE). Worldwide, GE Healthcare employees are committed to serving healthcare
professionals and their patients in more than 100 countries. For more
information about GE Healthcare, visit our website at www.gehealthcare.com.

About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer of
next-generation stem cell technologies for drug development, cell therapy,
tissue engineering and organ regeneration. CDI harnesses its unique
manufacturing technology to produce differentiated tissue cells from any
individual's stem cell line in industrial quality, quantity and purity. CDI is
accelerating the adoption of pluripotent stem cell technology, adapting its
methods to fit into standard clinical practice by the creation of individual
stem cell lines from a standard blood draw. CDI was founded in 2004 by Dr.
James Thomson, a pioneer in human pluripotent stem cell research at the
University of Wisconsin-Madison. CDI's facilities are located in Madison,
Wisconsin. See www.cellulardynamics.com.

Media Contacts:

GE Healthcare
Dr Val Jones, Global Media Relations Manager
E val.jones@ge.com
@GEHealthcare

College Hill
Dr Lynne Trowbridge, Tim Watson
T +44 207 866 7861
E GE-Corporate@collegehill.com

Cellular Dynamics International
Joleen Rau, Senior Director, Marketing & Communications
T +1 (608) 310-5142
jrau@cellulardynamics.com

Russo Partners LLC
Robert E. Flamm, Ph.D.
T +1 (212) 845-4226
robert.flamm@russopartnersllc.com



SOURCE Cellular Dynamics International, Inc.

Website: http://www.cellulardynamics.com
 
Press spacebar to pause and continue. Press esc to stop.